Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism
Channa Jayasena, Richard A. Anderson, Sofia Llahana, Julian H. Barth, Finlay MacKenzie, Scott Wilkes, Neil Smith, Prasanna Sooriakumaran, Suks Minhas, Frederick C. W. Wu, Jeremy Tomlinson, Richard Quinton
Abstract
Male hypogonadism (MH) is a common endocrine disorder. However, uncertainties and variations in its diagnosis and management exist. There are several current guidelines on testosterone replacement therapy that have been driven predominantly by single disciplines. The Society for Endocrinology commissioned this new guideline to provide all care providers with a multidisciplinary approach to treating patients with MH. This guideline has been compiled using expertise from endocrine (medical and nursing), primary care, clinical biochemistry, urology and reproductive medicine practices. These guidelines also provide a patient perspective to help clinicians best manage MH.